Walleye Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,029
Closed -$178K 4695
2026
Q1
$178K Sell
5,029
-16,568
-77% -$514K ﹤0.01% 3404
2025
Q4
$604K Buy
21,597
+20,034
+1,282% +$600K ﹤0.01% 2833
2025
Q3
$46.9K Buy
+1,563
New +$44.1K ﹤0.01% 4015
2024
Q3
Sell
-38,372
Closed -$925K 5214
2024
Q2
$925K Buy
38,372
+2,659
+7% +$65.2K ﹤0.01% 2927
2024
Q1
$967K Buy
+35,713
New +$1.01M ﹤0.01% 2623
2023
Q4
Sell
-6,377
Closed -$179K 4892
2023
Q3
$179K Buy
+6,377
New +$187K ﹤0.01% 3625
2022
Q3
Sell
-86,344
Closed -$2.57M 3199
2022
Q2
$2.57M Buy
+86,344
New +$2.48M 0.07% 298
2020
Q1
Sell
-18,758
Closed -$382K 869
2019
Q4
$382K Buy
+18,758
New +$373K 0.02% 808
2019
Q3
Sell
-14,292
Closed -$322K 1860
2019
Q2
$322K Buy
14,292
+11,237
+368% +$308K 0.04% 703
2019
Q1
$111K Buy
+3,055
New +$101K 0.02% 1001

Other funds holding ALKS

Walleye Capital's ALKS Position: Q2 2026 in Review

Walleye Capital sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 5,029 shares — an estimated $178K sold.

Walleye Capital first reported a position in ALKS in Q1 2019 and held it in 10 quarters. The position peaked at $2.57M in Q2 2022. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Walleye Capital reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 5,029 Alkermes shares in Q2 2026, an estimated $178K.
  • Walleye Capital first reported a position in Alkermes in Q1 2019 and held it in 10 quarters.
  • Walleye Capital's Alkermes position peaked at $2.57M in Q2 2022.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.